Market report
Dermatological drug tenders in Czechia — market report, February 2025
Dermatological drug tenders in Czechia in February 2025: 9,302 tenders published (+97% month on month, +37% year on year), estimated at €122,469 in total, and 9,292 contracts awarded (+97% month on month, +37% year on year), worth €86,091,598 (contract value). Buyers with the most tenders: Krajská nemocnice T. Bati, a. s. (3,712), Fakultní nemocnice Bulovka (2,227) and Krajská zdravotní, a.s. (716); most contracts won: ViaPharma s.r.o. (404), ROCHE s.r.o. (249) and Merck Sharp & Dohme s.r.o. (127). On average 1.8 bids per contract; 40% of contracts had a single bid. Report made on 27 October 2026.
- Tenders published
- 9,302
- Contracts awarded
- 9,292
- Contract value contract
- €86,091,598
- Bids per contract
- 1.8
The highlighted bar is February 2025. Hover a bar for its figure; the table below has every value.
| Figure | February 2025 | January 2025 | Change | February 2024 | Change |
|---|---|---|---|---|---|
| Tenders published | 9,302 | 4,714 | +97% | 6,766 | +37% |
| Estimated value | €122,469 | €584,738 | -79% | €80,693,989 | -100% |
| Buyers | 30 | 29 | +3% | 32 | -6% |
| Contracts awarded | 9,292 | 4,725 | +97% | 6,759 | +37% |
| Contract value (contract) | €86,091,598 | €82,678,669 | +4% | €57,603,438 | +49% |
| Winners | 267 | 229 | +17% | 282 | -5% |
| Bids per contract | 1.8 | 1.7 | — | — | — |
| Single-bid contracts | 40% | 69% | — | — | — |
Buyers with the most tenders
Companies with the most contracts
| # | Winners | Contracts |
|---|---|---|
| 1 | ViaPharma s.r.o. | 404 |
| 2 | ROCHE s.r.o. | 249 |
| 3 | Merck Sharp & Dohme s.r.o. | 127 |
| 4 | Janssen-Cilag s.r.o. | 126 |
| 5 | Amgen s.r.o. | 122 |
| 6 | Gilead Sciences s.r.o. | 119 |
| 7 | Avenier a.s. | 118 |
| 8 | Takeda Pharmaceuticals Czech Republic s.r.o. | 113 |
| 9 | AbbVie s.r.o. | 101 |
| 10 | FAGRON a.s. | 101 |
Where the tenders were
Procedures
The report's aggregates: the figures, the comparisons and the top lists by name and count.
All reports: Dermatological and musculoskeletal drugs
Questions and answers
- How many dermatological drug tenders were published in Czechia in February 2025?
- 9,302 (by 30 buyers); for comparison, January 2025: 4,714, February 2024: 6,766.
- Who won the most dermatological drug tenders in Czechia in February 2025?
- By number of contracts: ViaPharma s.r.o. (404), ROCHE s.r.o. (249), Merck Sharp & Dohme s.r.o. (127), Janssen-Cilag s.r.o. (126) and Amgen s.r.o. (122); 267 companies won contracts in all.
- Which buyers published the most dermatological drug tenders in February 2025?
- Krajská nemocnice T. Bati, a. s. (3,712), Fakultní nemocnice Bulovka (2,227), Krajská zdravotní, a.s. (716), Fakultní nemocnice Brno (311) and Nemocnice České Budějovice, a.s. (283).
- How competitive were dermatological drug tenders in Czechia in February 2025?
- On average 1.8 bids per contract (5 contracts with a known number of bids); 40% of contracts had a single bid.
- What were the contracts worth in February 2025?
- €86,091,598 (contract value, 9,292 contracts); median about €2,700.
How the report is made
Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.